Darcy Weidemann1, Chin-Chi Kuo2, Ana Navas-Acien3, Alison G Abraham4, Virginia Weaver3, Jeffrey Fadrowski5. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Division of Nephrology, Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: darcy@jhmi.edu. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USA. 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Division of Nephrology, Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Abstract
BACKGROUND: Long-term exposure to arsenic is a major public health concern. Emerging evidence suggests adverse health effects even at low levels of exposure. This study examined the association of arsenic exposure with estimated glomerular filtration rate (eGFR) and compared methods of adjustment for urinary dilution in a representative sample of U.S. adolescents and young adults. METHODS: We performed a cross-sectional study of 1253 participants ages 12-30 years in the 2009-2012 National Health and Nutrition Examination Survey (NHANES) with available urinary arsenic and eGFR measures. Multivariable linear regression was used to model the association of urinary total arsenic and dimethylarsinate (DMA) with eGFR. RESULTS: The median urinary total arsenic and DMA concentrations were 6.3 μg/L (IQR 3.3-12.7 μg/L) and 3.3 μg/L (IQR 1.7-5.7 μg/L), respectively. Median eGFR was 109 mL/min/1.73 m(2). Adjusting arsenic for urine concentration with urinary creatinine, eGFR was 4.0 mL/min/1.73 m(2) higher (95% confidence interval [CI] 1.0-7.1 mL/min/1.73 m(2)) and 4.3mL/min/1.73 m(2) higher (95% CI 0.5-8.0 mL/min/1.73 m(2)) per log-unit increase in total arsenic and DMA, respectively. When using urine osmolality to adjust for urine concentration, a log-unit increase in total arsenic and DMA was associated with a 0.4 mL/min/1.73 m(2) (95% CI -1.8 to 1.1 mL/min/1.73 m(2)) and 0.01 (95% CI -1.9 to 1.9 mL/min/1.73 m(2)) lower eGFR, respectively. CONCLUSIONS: Discordant associations were observed between arsenic and eGFR levels depending on whether urinary creatinine or osmolality was used to adjust for urine concentration. Further study should be dedicated to validating the best approach to account for urinary dilution in research in toxicants, and this may have implications for all studies which examine urinary biomarkers.
BACKGROUND: Long-term exposure to arsenic is a major public health concern. Emerging evidence suggests adverse health effects even at low levels of exposure. This study examined the association of arsenic exposure with estimated glomerular filtration rate (eGFR) and compared methods of adjustment for urinary dilution in a representative sample of U.S. adolescents and young adults. METHODS: We performed a cross-sectional study of 1253 participants ages 12-30 years in the 2009-2012 National Health and Nutrition Examination Survey (NHANES) with available urinary arsenic and eGFR measures. Multivariable linear regression was used to model the association of urinary total arsenic and dimethylarsinate (DMA) with eGFR. RESULTS: The median urinary total arsenic and DMA concentrations were 6.3 μg/L (IQR 3.3-12.7 μg/L) and 3.3 μg/L (IQR 1.7-5.7 μg/L), respectively. Median eGFR was 109 mL/min/1.73 m(2). Adjusting arsenic for urine concentration with urinary creatinine, eGFR was 4.0 mL/min/1.73 m(2) higher (95% confidence interval [CI] 1.0-7.1 mL/min/1.73 m(2)) and 4.3mL/min/1.73 m(2) higher (95% CI 0.5-8.0 mL/min/1.73 m(2)) per log-unit increase in total arsenic and DMA, respectively. When using urine osmolality to adjust for urine concentration, a log-unit increase in total arsenic and DMA was associated with a 0.4 mL/min/1.73 m(2) (95% CI -1.8 to 1.1 mL/min/1.73 m(2)) and 0.01 (95% CI -1.9 to 1.9 mL/min/1.73 m(2)) lower eGFR, respectively. CONCLUSIONS: Discordant associations were observed between arsenic and eGFR levels depending on whether urinary creatinine or osmolality was used to adjust for urine concentration. Further study should be dedicated to validating the best approach to account for urinary dilution in research in toxicants, and this may have implications for all studies which examine urinary biomarkers.
Authors: Laura Zheng; Chin-Chi Kuo; Jeffrey Fadrowski; Jackie Agnew; Virginia M Weaver; Ana Navas-Acien Journal: Curr Environ Health Rep Date: 2014-09-01
Authors: Rebecca Shelley; Nam-Soo Kim; Patrick Parsons; Byung-Kook Lee; Bernard Jaar; Jeffrey Fadrowski; Jacqueline Agnew; Genevieve M Matanoski; Brian S Schwartz; Amy Steuerwald; Andrew Todd; David Simon; Virginia M Weaver Journal: Occup Environ Med Date: 2012-07-26 Impact factor: 4.402
Authors: Molly L Kile; Elaine Hoffman; Yu-Mei Hsueh; Sakila Afroz; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Louise Ryan; David C Christiani Journal: Environ Health Perspect Date: 2008-11-19 Impact factor: 9.031
Authors: Yuri Levin-Schwartz; Maria D Politis; Chris Gennings; Marcela Tamayo-Ortiz; Daniel Flores; Chitra Amarasiriwardena; Ivan Pantic; Mari Cruz Tolentino; Guadalupe Estrada-Gutierrez; Hector Lamadrid-Figueroa; Martha M Tellez-Rojo; Andrea A Baccarelli; Robert O Wright; Alison P Sanders Journal: Children (Basel) Date: 2021-08-02